Yes, we are witnessing a profound shift
In untreated models, prolonged traversal times reflect significant coordination difficulties, comparable to the postural instability seen in Parkinsons patients, where such balance issues substantially impact patient safety and quality of life
The most common technical mistakes seen in practice are over-treating a single small area in one session in pursuit of faster results, inconsistent grid spacing leading to lumping, and skipping a proper pinch-test assessment on patients whose stubborn fat is actually loose skin or muscle laxity that fat dissolving wont address
We have not observed any difference in the rate of acute pancreatitis or gastrointestinal disturbance associated with GLP-1 RA compared to SGLT2i therapy and patients with type 1 diabetes
- Kt cu dng lng nh (ampoule) thm nhanh, khng gy bt dnh
Several GLP-1 RAs have additional FDA approval for: Heart protection : Dulaglutide [archived link], liraglutide [archived link], and semaglutide [archived link] have been proven to prevent strokes and heart attacks in people with risk factors, such as diabetes or obesity
